Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake

被引:25
|
作者
Martin-Gutierrez, G. [1 ,2 ]
Docobo-Perez, F. [2 ,4 ,5 ]
Rodriguez-Beltran, J. [2 ]
Rodriguez-Martinez, J. M. [2 ,4 ,5 ,7 ]
Aznar, J. [1 ,2 ,5 ]
Pascual, A. [2 ,3 ,4 ,5 ]
Blazquez, J. [1 ,4 ,6 ]
机构
[1] Hosp Univ Virgen del Rocio, Unidad Enfermedades Infecciosas Microbiol & Med P, Seville, Spain
[2] Inst Biomed Sevilla IBiS, Seville, Spain
[3] Hosp Univ Virgen Macarena, Unidad Enfermedades Infecciosas & Microbiol, Seville, Spain
[4] Inst Salud Carlos III, REIPI, Madrid, Spain
[5] Univ Seville, Dept Microbiol, Seville, Spain
[6] CSIC, Ctr Nacl Biotecnol, Madrid, Spain
[7] Hosp Univ Ramon y Cajal IRYCIS, Dept Microbiol, Madrid, Spain
关键词
fosfomycin activity; fosfomycin resistance; chromosomal mutations; UTI; Escherichia coli; urinary tract infection; RESISTANT KLEBSIELLA-PNEUMONIAE; DOSE ORAL TREATMENT; INTRAVENOUS FOSFOMYCIN; BACTERIAL-GROWTH; INFECTIONS; IMPACT; TISSUE; PHOSPHONOMYCIN; SUSCEPTIBILITY; EPIDEMIOLOGY;
D O I
10.1128/AAC.01899-17
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The steps by which Escherichia coli strains harboring mutations related to fosfomycin (FOS) resistance arise and spread during urinary tract infections (UTIs) are far from being understood. The aim of this study was to evaluate the effects of urine, pH, and anaerobiosis on FOS activity against a set of isogenic strains carrying the most prevalent chromosomal mutations conferring FOS resistance (Delta uhpT,Delta glpT,Delta cyaA, and Delta ptsI), either singly or in combination. We also studied fosfomycin-resistant E. coli clinical isolates from patients with UTI. Our results demonstrate that urinary tract physiological conditions might have a profound impact on FOS activity against strains with chromosomal FOS resistance mutations. Specifically, acidic pH values and anaerobiosis convert most of the strains categorized as resistant to fosfomycin according to the international guidelines to a susceptible status. Therefore, urinary pH values may have practical interest in the management of UTIs. Finally, our results, together with the high fitness cost associated with FOS resistance mutations, might explain the low prevalence of fosfomycin-resistant E. coli variants in UTIs.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections
    Alos, J. I.
    Garcia-Pena, P.
    Tamayo, J.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2007, 20 (02) : 211 - 215
  • [22] Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from Australia
    Mowlaboccus, Shakeel
    Daley, Denise
    Pang, Stanley
    Gottlieb, Thomas
    Merlino, John
    Nimmo, Graeme R.
    George, Narelle
    Korman, Tony M.
    Streitberg, Richard
    Robson, Jenny
    Peachey, Georgia
    Collignon, Peter
    Bradbury, Susan
    Colombi, Elena
    Ramsay, Joshua P.
    Rogers, Benjamin A.
    Coombs, Geoffrey W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (04)
  • [23] Prevalence and risk factors for fosfomycin resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection
    Ramos, Javier
    Teresa Bastida, Maria
    Nino, Esther
    Smithson, Alex
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2019, 37 (07): : 484 - 485
  • [24] Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
    Wang, Lei
    Di Luca, Mariagrazia
    Tkhilaishvili, Tamta
    Trampuz, Andrei
    Moreno, Mercedes Gonzalez
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [25] Fosfomycin as a salvage therapy for treating urinary tract infections due to multidrug-resistant Escherichia coli
    Nordmann, Patrice
    Sadek, Mustafa
    Poirel, Laurent
    Chakraborty, Trinad
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (04) : 689 - 690
  • [26] Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia
    Mowlaboccus, Shakeel
    Daley, Denise A.
    Birdsall, Jacob
    Gottlieb, Thomas
    Merlino, John
    Nimmo, Graeme R.
    George, Narelle
    Korman, Tony
    Streitberg, Richard
    Robson, Jenny
    Peachey, Georgia
    Collignon, Peter
    Bradbury, Susan
    Rogers, Benjamin A.
    Coombs, Geoffrey W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1360 - 1361
  • [27] Activity of fosfomycin against extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae
    de Cueto, Marina
    Hernandez, Jose R.
    Lopez-Cerero, Lorena
    Morillo, Concepcin
    Pascual, Alvaro
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2006, 24 (10): : 613 - 616
  • [28] In Vitro Activity of Fosfomycin Against Extended Spectrum-beta-Lactamase (ESBL) Producing Escherichia coli and Klebsiella pneumoniae Strains
    Asik, Gulsah
    Ciftci, Hsan Hakki
    Aktepe, Orhan Cem
    Cetinkaya, Zafer
    Altindis, Mustafa
    TURKISH JOURNAL OF IMMUNOLOGY, 2008, 13 (01): : 1 - 4
  • [29] Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
    Seo, Mi-Ran
    Kim, Seong-Jong
    Kim, Yeonjae
    Kim, Jieun
    Choi, Tae Yeal
    Kang, Jung Oak
    Wie, Seong-Heon
    Ki, Moran
    Cho, Young Kyun
    Lim, Seung-Kwan
    Lee, Jin Seo
    Kwon, Ki Tae
    Lee, Hyuck
    Cheong, Hee Jin
    Park, Dae Won
    Ryu, Seong Yeol
    Chung, Moon-Hyun
    Pai, Hyunjoo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (08) : 1178 - 1181
  • [30] Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK
    Cottell, Jennifer L.
    Webber, Mark A.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (02) : 161 - 168